Aikya Investment Management Ltd holds a concentrated book of 5 stocks worth $340.6M as of Q2 2026 (disclosed Aug 12, 2026, a ~43-day 13F lag). This quarter they opened Makemytrip Ltd and trimmed HDFC Bank Ltd-ADR. Their largest long position is DR. Reddy's Laboratories-ADR at 36% of the equity book.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Aikya Investment Management Ltd
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| MORGAN STANLEY | 5 / 5 | $1.7B |
| ROYAL BANK OF CANADA | 5 / 5 | $1.4B |
| JPMORGAN CHASE & CO | 5 / 5 | $1.2B |
| Robeco Institutional Asset Management B.V. | 5 / 5 | $1.1B |
| BlackRock, Inc. | 5 / 5 | $995.0M |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 5 / 5 | $883.7M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 5 / 5 | $567.7M |
| UBS Group AG | 5 / 5 | $484.0M |
Ranked by how many of Aikya Investment Management Ltd's top 5 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Dr. Reddy's Laboratories Limited ADR | $123.1M | 8.49M | 36.1% | ▲+6.2% Added · +494K sh | |
| 2 | EPAM Systems Inc Common Stock | $108.4M | 1.37M | 31.8% | ▲+50% Added · +455K sh | |
| 3 | HDFC Bank Limited ADR | $105.4M | 4.08M | 31.0% | ▼−1.0% Reduced · −42K sh | |
| 4 | Infosys Ltd ADR | $3.7M | 352.9K | 1.1% | ▼−41% Reduced · −243K sh | |
| 5 | MakeMyTrip LTD Common Stock | $28K | 525 | 0.0% | ▲New New position |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/2005403/holdings"
Use Arkolith to show Aikya Investment Management Ltd's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 12, 2026 | 5 | $340.6M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 5, 2026 | 4 | $344.7M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 2, 2026 | 4 | $441.0M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 4, 2025 | 4 | $357.2M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 5, 2025 | 4 | $333.5M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 | 4 | $269.8M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 11, 2025 | 3 | $240.2M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 15, 2024 | 3 | $180.0M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.